Chang Gung hospital
Taoyuan City, 333, Taiwan
NCT Number: NCT05566236
The study aims to investigate the effectiveness of using a board game to improve adolescents' tics, mental health, and interpersonal interactions.
Looking for future studies?
Notify Me12 year–18 year
All sexes
Interventional
Not applicable
Taoyuan City, 333, Taiwan
This study utilizes a randomized control study design. According to the situated learning theory and qualitative research findings, this study develops a board game. This study enrolled adolescents with Tourette syndrome aged 12 to 18 as the subjects. Participants played board games at home at least once (about 60 minutes) a week for four consecutive weeks. The control group received the usual standard of care (psychoeducation regarding Tourette Syndrome and one 50-mg tablet of pyridoxine daily). The effectiveness indicators include self-reported status of positive mental health, tics severity, social adjustment, and depression by adolescents with TS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
· Adolescents with Tourette Syndrome have mental illness and serious diseases.
A board game was designed based on situated learning theory and the results of relevant studies. This board game contains a summary, answer booklet, and multiple card game tasks including situations of interpersonal interaction. The participants must discuss, share personal experiences, and find the answer together.
Other names: Non
Time frame: Pre-intervention (baseline), immediately after completion of the intervention (4 weeks after baseline) and at follow-up (12 weeks post-baseline).
This study will use the Positive Mental Health Scale(25 items) to evaluate adolescents' degree of positive mental health. The lowest and highest total scores were 25 and 125, respectively. A high score indicates favorable positive mental health.
Time frame: Pre-intervention (baseline), immediately after completion of the intervention (4 weeks after baseline) and at follow-up (12 weeks post-baseline).
The Yale Global Tic Severity Scale (YGTSS) will assess participants' motor and vocal tics' frequency, intensity, number, complexity, and interference. YGTSS also includes an overall Impairment Rating to determine each participant's interpersonal, academic, and occupational skill domains. Finally, the Global Severity Score will be acquired by adding the Total Motor Tic Score(0-25), Total Vocal Tic Score (0-25), and Overall Impairment Rating (0-50). The YGTSS has a total score ranging from 0 to 100, with the high score indicating a higher tics severity.
Time frame: Pre-intervention (baseline), immediately after completion of the intervention (4 weeks after baseline) and at follow-up (12 weeks post-baseline).
This study will use the social adjustment scale for adolescents with Tourette syndrome(17 items) to assess participants' level of social adjustment. The lowest and highest total scores were 17 and 68, respectively. A high score indicates favorable social adjustment.
Time frame: Pre-intervention (baseline), immediately after completion of the intervention (4 weeks after baseline) and at follow-up (12 weeks post-baseline).
Chinese Version Beck Youth Inventories II (depression inventory)will used in this research to evaluate adolescents' depression. The depression inventory(20 items) has a total score ranging from 0 to 60, with a high score indicating a higher depression.
National Taipei University of Nursing and Health Sciences
Other
Study on the Effectiveness of an Evidence-based Board Game Project to Help Improve Tics and Interpersonal Interactions of Adolescents with Tourette Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05628805
Basal Ganglia Diseases, Brain Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05696769
Basal Ganglia Diseases, Behavior
Winston-Salem, North Carolina, United States
View Trial DetailsNCT04578912
Basal Ganglia Diseases, Brain Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT04114539
Basal Ganglia Diseases, Brain Diseases
Dothan, Alabama, United States
View Trial Details